Evidence map›Paper›PMID 28795692›Full record

ArticleActa pharmacologica Sinica2017

The novel resveratrol derivative 3,5-diethoxy-3',4'-dihydroxy-trans-stilbene induces mitochondrial ROS-mediated ER stress and cell death in human hepatoma cells in vitro.

Jae-Woo Park, Woo-Gyun Choi, Phil-Jun Lee, Su-Wol Chung, Byung-Sam Kim, Hun-Taeg Chung, Sungchan Cho, Jong-Heon Kim, Byoung-Heon Kang, Hyoungsu Kim and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jae-Woo ParkSchool of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Woo-Gyun ChoiSchool of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Phil-Jun LeeSchool of Pharmacy, Ajou University, Suwon 16499, Korea.
Su-Wol ChungSchool of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Byung-Sam KimSchool of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Hun-Taeg ChungSchool of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Sungchan ChoTargeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongwon, Chungbuk 28116, and Department of Biomolecular Science, University of Science and Technology, Daejeon 34554, Korea.
Jong-Heon KimCancer Cell and Molecular Biology Branch, Research Institute, and Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Byoung-Heon KangSchool of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
Hyoungsu KimSchool of Pharmacy, Ajou University, Suwon 16499, Korea.
Hong-Pyo KimSchool of Pharmacy, Ajou University, Suwon 16499, Korea.
Sung-Hoon BackSchool of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
University of Ulsan · KRAjou University · KRKorea Research Institute of Bioscience and Biotechnology · KRNational Cancer Center · KRUlsan National Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a well-known polyphenol that is present in grapes, peanuts, pine seeds, and several other plants. Resveratrol exerts deleterious effects on various types of human cancer cells. Here, we analyzed the cell death-inducing mechanisms of resveratrol-006 (Res-006), a novel resveratrol derivative in human liver cancer cells in vitro. Res-006 was more effectively suppressed the viability of HepG2 human hepatoma cells than resveratrol (the IC

Indexed as

Antineoplastic Agents, PhytogenicApoptosisCarcinoma, HepatocellularDose-Response Relationship, DrugEndoplasmic Reticulum StressHep G2 CellsHumansInhibitory Concentration 50Liver NeoplasmsMembrane Potential, MitochondrialMitochondriaOxidative StressReactive Oxygen SpeciesStilbenesTime FactorsAntineoplastic Agents, PhytogenicReactive Oxygen SpeciesStilbenes

Identifiers

PMID28795692
PMCPMC5672065
OpenAlexW2742522584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.